Alec James Coppen

Alec James Coppen's AcademicInfluence.com Rankings

Alec James Coppen

Biology

#4834

World Rank

#7157

Historical Rank

Biochemistry

#521

World Rank

#609

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Alec James Coppen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alec James Coppen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Biochemistry of Affective Disorders (1967) (1122)
Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. (2000) (368)
Treatment of depression: time to consider folic acid and vitamin B12 (2005) (329)
Prophylactic lithium in affective disorders. Controlled trial. (1971) (322)
Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. (1963) (316)
Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. (1968) (297)
Abnormalities of indoleamines in affective disorders. (1972) (286)
Tryptophan in the treatment of depression. (1967) (271)
Ageing, monoamines, and monoamine-oxidase levels. (1972) (247)
Dexamethasone Suppression Test in Depression and other Psychiatric Illness (1983) (242)
Plasma concentration of amitriptyline and clinical response. (1972) (241)
The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. (1972) (239)
Platelet 5-hydroxytryptamine accumulation in depressive illness. (1978) (198)
Folate deficiency in depressive illness. (1970) (182)
Folic acid enhances lithium prophylaxis. (1986) (161)
Mineral metabolism in mania. (1966) (151)
Does lithium reduce the mortality of recurrent mood disorders? (1991) (142)
Tryptamine Metabolism in Depression (1965) (141)
Mineral Metabolism in Melancholia (1963) (141)
PROPHYLACTIC TREATMENT OF ALCOHOLISM BY LITHIUM CARBONATE A Controlled Study (1976) (127)
Indoleamines and affective disorders. (1972) (119)
A Comparison Between the Hamilton Rating Scale and the Beck Inventory in the Measurement of Depression (1976) (112)
Effect of a Depressive Illness on M.P.I. Scores (1965) (109)
Mianserin Hydrochloride: A Novel Antidepressant (1976) (109)
AMITRIPTYLINE PLASMA-CONCENTRATION AND CLINICAL EFFECT A World Health Organisation Collaborative Study (1978) (106)
Serotonin and its place in the pathogenesis of depression. (1988) (105)
Thyroid function and the response to liothyronine in depression. (1972) (103)
A Double-Blind Comparison of Lithium Carbonate and Maprotiline in the Prophylaxis of the Affective Disorders (1976) (101)
Deficient production of tyramine and octopamine in cases of depression (1979) (99)
Continuation Therapy with Amitriptyline in Depression (1978) (99)
Serum and red blood cell folate in depression (1989) (99)
Depression and tetrahydrobiopterin: the folate connection. (1989) (96)
Total and free tryptophan concentration in the plasma of depressive patients. (1973) (92)
Thyrotrophin-releasing hormone in the treatment of depression. (1974) (92)
Plasma Folate and Affective Morbidity During Long-Term Lithium Therapy (1982) (90)
Who responds to prophylactic lithium? (1986) (87)
Depression as a lethal disease: prevention strategies. (1994) (87)
The Prevalence of Menstrual Disorders in Psychiatric Patients (1965) (87)
The prevalence of common menstrual symptoms. (1963) (85)
Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness. (1979) (84)
The biology of folate in depression: implications for nutritional hypotheses of the psychoses. (1986) (83)
Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis. (1983) (80)
Plasma Magnesium and Calcium in Depression (1969) (78)
Mineral Metabolism in Affective Disorders (1965) (75)
Antidepressant evaluation and the pharmacological actions of FG4963 in depressive patients. (1977) (73)
The Marke-Nyman temperament scale: an English translation. (1966) (69)
Changes in Psychological Symptoms in Women Taking Oral Contraceptives (1970) (69)
Folic acid and the treatment of depression. (2006) (68)
Seasonal variations in biochemical factors related to depressive illness. (1980) (67)
5-Hydroxytryptamine (5-HT) in the whole-blood of patients with depressive illness (1976) (67)
Renal function in lithium and non‐lithium treated patients with affective disorders (1980) (66)
Total and free tryptophan concentration in the plasma of depressive patients. (1972) (66)
Lithium Continuation Therapy Following Electroconvulsive Therapy (1981) (66)
Lithium Restores Abnormal Platelet 5-HT Transport in Patients with Affective Disorders (1980) (65)
Prophylactic Use of Anticholinergics in Patients on Long-Term Neuroleptic Treatment (1990) (65)
Electrodermal Activity in Depression: Clinical and Biochemical Correlates (1980) (64)
INTRAVENOUS TYRAMINE PRESSOR RESPONSE IN DEPRESSION (1975) (64)
3-Methoxy-4-hydroxyphenylglycol in depression (1973) (64)
EFFECTS OF LITHIUM CARBONATE ON ELECTROLYTE DISTRIBUTION IN MAN. (1965) (63)
ABNORMALITY OF THE BLOOD-CEREBROSPINAL FLUID BARRIER OF PATIENTS SUFFERING FROM A DEPRESSIVE ILLNESS (1960) (61)
Tryptophan concentration in the cerebrospinal fluid of depressive patients. (1972) (58)
The distribution of electrolytes and water in patients after taking lithium carbonate. (1967) (57)
Double-blind and open prospective studies on lithium prophylaxis in affective disorders. (1973) (56)
Clinical State, Plasma Levels of Haloperidol and Prolactin: A Correlation Study in Chronic Schizophrenia (1980) (54)
5-hydroxytryptamine in psychiatry : a spectrum of ideas (1991) (54)
Plasma II-Hydroxycorticosteroids in Affective Disorders (1967) (53)
Cancer and Extraversion (1963) (53)
Relationship between mood disturbances and free and total plasma tryptophan in postpartum women. (1976) (53)
Mianserin and Lithium in the Prophylaxis of Depression (1978) (53)
Psychopharmacology of Affective Disorders (1981) (53)
Tryptophan and depressive illness (1978) (52)
HYSTERECTOMY, HORMONES, AND BEHAVIOUR A Prospective Study (1981) (51)
Classification of depression and response to amitriptyline therapy (1979) (51)
Changes in 5-Hydroxytryptophan Metabolism in Depression (1965) (49)
Depressed states and indolealkylamines. (1968) (48)
Neuroendocrine studies in affective disorders. Part 1. Plasma prolactin response to thyrotropin-releasing hormone in affective disorders: effect of ECT. (1980) (47)
Bromocriptine and premenstrual syndrome: controlled study. (1977) (44)
Classification of Depression and Response to Antidepressive Therapies (1983) (44)
PLATELET 5-HYDROXYTRYPTAMINE ACCUMULATION AND MIGRAINE (1979) (44)
Suicide mortality in patients on lithium maintenance therapy. (1998) (44)
Levodopa and L-tryptophan therapy in Parkinsonism. (1972) (44)
Biological Aspects of Affective Psychoses (1975) (43)
Lithium in unipolar depression and the prevention of suicide. (2000) (42)
Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depression (2017) (42)
PLASMA-TRYPTOPHAN IN ANOREXIA NERVOSA (1976) (41)
Dexamethasone suppression test in alcoholism (1984) (41)
Biochemical aspects of depression. (1969) (41)
The Hamilton Scales (1990) (40)
Cyclic A.M.P. in affective disorders. (1970) (40)
TETRAHYDROBIOPTERIN METABOLISM IN DEPRESSION (1984) (40)
Lithium therapy: from clinical trials to practical management (1988) (39)
Classification of depressive illness. Clinico-psychological correlates. (1984) (39)
Long-term lithium and mortality (1990) (39)
The Prognosis of Depression in Old Age: The Case for Lithium Therapy (1983) (37)
Tryptophan metabolism in depressive illness (1974) (34)
5-Hydroxytryptamine in the pathogenesis of affective disorders. (1982) (33)
Abnormal Dexamethasone Suppression Test in Type II Schizophrenia (1985) (33)
Methysergide in mania. A controlled trial. (1969) (32)
Early improvement as a predictor of response to amitriptyline and nortriptyline: a comparison of 2 patient samples (1982) (32)
Platelet Alpha-Adrenoreceptor Sensitivity in Depressive Illness (1981) (31)
The efficacy of low-dose lithium: clinical, psychological and biological correlates. (1989) (31)
Chapter III – Mania and depression (1968) (30)
Intravenous tyramine response in migraine before and during treatment with indoramin. (1977) (28)
Psychosomatic aspects of pre-eclamptic toxaemia. (1958) (27)
Subjective Side-Effects of Amitriptyline and Lithium in Affective Disorders (1983) (27)
Frusemide: a safe diuretic during lithium therapy? (1983) (27)
Zimelidine: A therapeutic and pharmacokinetic study in depression (1979) (27)
Distribution of Androgyny in Mental Patients (1959) (26)
Prophylactic treatment of alcoholism by lithium carbonate: an initial report. (1977) (26)
Lymphocyte beta-adrenergic receptor density of patients with recurrent affective illness. (1986) (25)
Apparent supersensitivity of platelet 5-HT receptors in lithium-treated patients. (1985) (25)
5-Hydroxytryptamine in Psychiatry (1991) (25)
α2-ADRENERGIC RECEPTORS IN DEPRESSION (1982) (25)
Maternal Health and Mongolism (1960) (24)
ENDOCRINE PROFILES IN PREMENSTRUAL TENSION (1972) (24)
Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness (1976) (24)
The Dexamethasone Suppression Test in Depression (1987) (23)
Cortisol levels in depression. (1976) (23)
Peripheral serotonergic receptor sensitivity in depressive illness. (1984) (23)
Body Build and Urinary Steroid Excretion in Mental Illness (1967) (22)
The effect of antidepressant drugs on plasma kynurenine in depressed patients (1978) (22)
Total Exchangeable Sodium in Depressive Illness (1962) (22)
L-tryptophan in depression. (1970) (22)
Effect of mianserin hydrochloride on peripheral uptake mechanisms for noradrenaline and 5-hydroxytryptamine in man. (1978) (21)
20 most-cited countries in clinical medicine ranked by population size (2004) (21)
Cortisol in the cerebrospinal fluid of patients suffering from affective disorders (1971) (21)
Nuclear Sex and Body-build in Schizophrenia (1960) (21)
Biogenic Amines and Affective Disorders (1971) (21)
Defects in monoamine metabolism and their possible importance in the pathogenesis of depressive syndromes. (1969) (21)
Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders. (1983) (20)
Neuroendocrine studies in affective disorders. Part 2. Plasma thyroid-stimulating hormone response to thyrotropin-releasing hormone in affective disorders: effect of ECT. (1980) (20)
Androgen Excretion and Physique in Schizophrenia (1970) (20)
Plasma Trytophan and Sleep (1974) (20)
Slow-release lithium carbonate. (1969) (20)
5-HT and Depression: the Present Position (1988) (19)
Antinuclear antibodies, affective disorders and lithium therapy. (1977) (19)
Technique and Accuracy of the Dexmethasone Suppression Test (1983) (19)
Continuation Therapy with Antidepressants After Electroconvulsive Therapy. (1988) (19)
Vomiting of early pregnancy; psychological factors and body build. (1959) (19)
Steroid excretion in mothers of mongols. (1961) (19)
Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness (1979) (18)
Lithium treatment and prophylaxis in unipolar depression. (1980) (18)
FAMILIAL ASPECTS OF "NEUROTICISM" AND "EXTRAVERSION". (1965) (17)
The dexamethasone suppression test in medicated epileptic patients (1986) (17)
Workshop on the clinical pharmacology and efficacy of mianserin. (1978) (17)
Effect of intravenous acetazolamide on cerebrospinal-fluid pressure. (1957) (17)
LITHIUM AND MEMORY IMPAIRMENT (1978) (16)
Body-build of Male Homosexuals (1959) (16)
Prophylactic lithium treatment of patients with affective disorders is associated with decreased platelet [3H]dihydroergocryptine binding. (1983) (16)
Antithymic Immune Factor in Schizophrenia (1980) (16)
A clinical and pharmacodynamic evaluation of sulpiride (2004) (15)
Beta blockade in lithium tremor. (1975) (15)
Inhibition of 5-hydroxytryptamine reuptake by amitriptyline and zimelidine and its relationship to their therapeutic action (1979) (15)
HYSTERECTOMY, HORMONES, AND BEHAVIOUR (1981) (15)
Letter: Total and free plasma-tryptophan concentration and oral contraception. (1973) (15)
Puerperal Affective Disorders and Response to Lithium (1983) (15)
The Effect of Plasma from Schizophrenic Patients on the Chicken Erythrocyte System (1963) (15)
Aspects of Personality of Depressive Patients (1969) (14)
ANTIDEPRESSANT DRUG LEVELS AND CLINICAL RESPONSE (1978) (14)
Comparison of methods for the determination of total and free tryptophan in plasma. (1977) (14)
TRACE AMINE DEFICIT IN DEPRESSIVE ILLNESS: THE PHENYLALANINE CONNEXION (1980) (14)
TREATMENT OF UNIPOLAR DEPRESSION (1976) (13)
Glucose Tolerance in Depression (1968) (12)
Urine concentration in depressive illness (1971) (12)
Recent developments in schizophrenia : a symposium (1967) (12)
Seasonal variations in the dexamethasone suppression test. (1987) (12)
ROLE OF SEROTONIN IN AFFECTIVE DISORDERS (1973) (12)
IMPAIRMENT OF RENAL-CONCENTRATING CAPACITY BY LITHIUM (1978) (11)
Absence of platelet monamine oxidase inhibition during amitriptyline or zimelidine treatment. (1979) (11)
Effects of piperazine oestrone sulphate on plasma tryptophan, oestrogens, gonadotropins and psychological functioning in women following hysterectomy (1977) (11)
Decreased tryptophan excretion by depressive patients. (1978) (10)
Clinical significance of plasma levels of tricyclic antidepressant drugs in the treatment of depression. (1973) (10)
Familial Aspects of “Neuroticism” and “Extraversion” (1965) (10)
PLATELET ACCUMULATION OF HISTAMINE IN DEPRESSION (1983) (10)
Urinary free cortisol and clinical classification of depressive illness (1981) (10)
The influence of sodium amytal on the respiratory abnormalities of anxious psychiatric patients. (1960) (10)
Noradrenaline, depressive illness, and the action of amitriptyline (1977) (9)
Alcoholism, Depression and Plasma Folate (1982) (9)
Dexamethasone suppression test in depression (1983) (9)
Platelet accumulation of histamine in controls, depressed and lithium-treated patients. (1984) (9)
Saliva–Serum Ratios of Tritium after the Administration of Tritiated Water (1960) (9)
50 years of lithium treatment of mood disorders. (1999) (8)
Electrolyte and water distribution in familial hypokalaemic periodic paralysis (1966) (8)
Blood platelet 5-hydroxytryptamine accumulation and migraine. (1980) (8)
Trials with antidepressants reassessed. (1976) (8)
Antidepressant activity and pharmacological interactions of ciclazindol (1978) (8)
The effect of clofibrate on total and free plasma tryptophan in depressed patients (1978) (7)
PERIPHERAL SEROTONERGIC AND ADRENERGIC RESPONSES IN DEPRESSION (1980) (7)
Clinical and pharmacological effects of treatment with a new antidepressant. (1976) (7)
Metabolic effect of venepuncture in man. (1960) (7)
MENSTRUAL DISORDERS AND PERSONALITY. (1963) (7)
AMITRIPTYLINE AND ITS DEMETHYLATION-RATE (1979) (6)
The chemical pathology of the affective disorders. (1970) (6)
Adrenergic and serotonergic mechanisms in depression and their response to amitriptyline. (1979) (6)
Peripheral α-adrenoreceptor and central dopamine receptor activity in depressive patients (1978) (6)
Indolamines and affective disorders (1972) (6)
Mianserin in the prophylactic treatment of bipolar affective illness. (1977) (6)
A double blind comparison of lithium carbonate and ludiomil in the prophylaxis of unipolar affective illness. (1976) (6)
Increased platelet monoamine oxidase activity in affective disorders (2004) (6)
Peripheral alpha-adrenoreceptor and central dopamine receptor activity in depressive patients. (1978) (6)
The effect of nitrazepam and other hypnotics on platelet 5-HT uptake. (1981) (5)
An Analysis of the Marke‐Nyman Temperament Scale (1975) (5)
BLOOD-CEREBROSPINAL FLUID BROMIDE RATIOS IN MENTAL PATIENTS (1959) (5)
Trace amine deficit in depressive illness: the phenylalanine connexion. (1980) (5)
TOTAL AND NON-BOUND PLASMA-TRYPTOPHAN IN DEPRESSIVE ILLNESS (1977) (5)
Plasma tryptophan binding and depression. (1974) (5)
The Role of Lithium Carbonate in the Treatment and Prophylaxis of the Affective Disorders (1973) (5)
Plasma tryptophan and sheep. (1974) (5)
Chairman's Summing Up (1976) (4)
Renal Enzymes in Lithium Treatment (1983) (4)
The action of antidepressant drugs on 5‐hydroxy‐tryptamine uptake by platelets ‐ relationship to therapeutic effect (1981) (4)
Pituitary-adrenal activity during psychosis and depression. (1970) (4)
Disorders of mineral metabolism in depressive patients. (1969) (4)
ABNORMALITYOF THE BLOOD-CEREBROSPINAL FLUID BARRIEROF PATIENTSSUFFERINGFROM A DEPRESSIVEILLNESS (1960) (4)
The influence of isoprenaline and prednisone on the respiratory adaptation of normal subjects. (1960) (4)
Blood platelet 5-hydroxytryptamine accumulation and migraine. (1982) (3)
EVERYDAY MANAGEMENT OF AFFECTIVE DISORDERS (1987) (3)
Lithium and the kidney. (1980) (3)
Dexamethasone Suppression Test in Dementia (1987) (3)
The effective dosage of antidepressants. (1976) (3)
Effect of acetazolamide on metabolic rate of man. (1961) (3)
Reduced Lithium Dosage Improves Prophylaxis A Possible Mechanism (1986) (3)
WHO RESPONDS TO AMITRIPTYLINE? (1980) (3)
Protein-bound iodine in phenylketonuria. (1959) (3)
Biological classification of depressive illness. (1983) (3)
Peripheral alpha-adrenergic activity in the affective disorders. (1982) (3)
Assessment of drugs in schizophrenia. Discussion on basic trial design. (1976) (3)
Red cell adenylate kinase phenotypes in the affective disorders (1977) (3)
Letter: Tryptophan in depression. (1974) (3)
DO TRICYCLIC ANTIDEPRESSANTS WORK? (1976) (3)
British Academy of Psychopharmacology (1974) (2)
Platelet alpha-adrenergic receptors in depression: ligand binding and aggregation studies. (1985) (2)
Erythrocyte adenylate kinase activity in affective disorders (1978) (2)
PLASMA AMITRIPTYLINE AND CLINICAL EFFECT (1978) (2)
Electrolytes and mental illness. (1969) (2)
LITHIUM AND MORTALITY: A 15 YEAR FOLLOW‐UP (1992) (2)
Respiratory adaptation to exercise in anxious patients. (1961) (2)
DOUBLE BLIND COMPARATIVE STUDY OF MIANSERIN VS PLACEBO IN THE PROPHYLAXIS OF MIGRAINE (1984) (2)
Sustained-Release Lithium Carbonate (1970) (2)
The transfer of 35S-methionine sulphone across the blood-cerebrospinal fluid barrier1 (1963) (2)
Strategies for the testing of antidepressants: trials and tribulations. An overview (1983) (2)
DISCUSSION — SESSION II (1983) (1)
Pharmacokinetics and pharmacodynamics of amitriptyline in depression. (1979) (1)
Towards the 17th Congress — Kyoto 1990 (1988) (1)
Acute Treatment, Long-term Management, and Prophylaxis of Affective Disorders (1987) (1)
[Indoleamine precursors in depression (author's transl)]. (1979) (1)
Antithymic immune factor in schizophrenia. A World Health Organization study. (1980) (1)
2. PSYCHIATRY: A Psycho-somatic Approach to Cystic Glandular Hyperplasia of the Endometrium. (1964) (1)
The biochemistry of therapy-resistant depression. Contributions to biochemistry. (1974) (1)
Tetrahydrobiopterin metabolism in senile dementia of the Alzheimer type (SDAT) (1987) (1)
Dehydroepiandrosterone excretion in the mothers of mongols. (1966) (1)
BIOLOGICALCLASSIFICATION OF DEPRESSIVEILLNESS (1983) (1)
Effect of mianserin hydrochloride on peripheral uptake mechanisms for noradrenaline and 5-HT in man (1978) (1)
Treatment of bipolar affective illness with zimeldine, a 5-HT uptake inhibitor. (1984) (1)
TSH response to TRH stimulation in depression: Effects of endogenicity (1988) (1)
Letter: Do tricyclic antidepressants work? (1976) (1)
Tryptophan accumulation by blood platelets of depressed patients. (1979) (1)
alpha 2-Adrenergic receptors in depression. (1982) (1)
TRACE AMINES IN DEPRESSION: TYRAMINE AND OCTOPAMINE DEFICIT (1979) (1)
Hormonal Influences on α-Adrenoreceptors: Preliminary Results (1980) (1)
Do Chronic Schizophrenics in Hospital Need More Than One Neuroleptic Drug? (1979) (1)
Personality and body build in pre-eclamptic toxemia. (1958) (1)
Plasma Immunoglobulins in Depressed and Lithium-treated Patients (1985) (1)
Depressive illness : biological and psychopharmacological issues : Symposium on Depressive Illness, Amsterdam, September 11-12, 1980 (1981) (0)
A Reply to Sackeim et al. (1989) (0)
Lithium revisited. (1996) (0)
Research on the Aetiology of Schizophrenia (1963) (0)
Headaches, Depression and 5-Hydroxytryptamine (1984) (0)
Chlorpromazine Jaundice (1958) (0)
Proceedings of the 17th Collegium Internationale Neuro-psychopharmacologicum Congress (1990) (0)
TYRAMINE PRESSOR RESPONSE IN DEPRESSION (1975) (0)
PLATELET ACCUMULATION OF HISTAMINE: A BIOLOGICAL MARKER OF DEPRESSION? (1984) (0)
Body-build of male homosexuals. (1960) (0)
Physiological Correlates of Psychological Disorder (1963) (0)
Title Page / Contents / Introduction (1981) (0)
Obituary (1978) (0)
Contents, Vol. 6, 1980 (2004) (0)
Acknowledgement to assessors (1995) (0)
Ole J. Rafaelsen, 1930–1987 (1988) (0)
Chairman's introduction (1992) (0)
Book Reviews / Announcement (1980) (0)
Letter: British Academy of Psychopharmacology. (1974) (0)
[No Title] (1965) (0)
The administration of post-menopausal oestrogens and the need for long-term controlled trials. (1976) (0)
Chairman's summary (1992) (0)
Letter: Plasma-tryptophan in anorexia nervosa. (1976) (0)
Chapter Seven Lithium in the prophylaxis 01 depressive illness in late lile (1989) (0)
Current concepts of lithium therapy. (1981) (0)
PLATELET α‐ADRENERGIC RECEPTORS IN DEPRESSION: LIGAND BINDING AND AGGREGATION STUDIES. (2009) (0)
disorders.side-effects of amitriptyline and lithium in affective (2013) (0)
Letter: Tyramine pressor response in depression. (1975) (0)
Folate Deficiency in Depressive Illness (1970) (0)
Peripheral serotonergic and adrenergic responses in depression. (1980) (0)
Novel antidepressants: problems in evaluation. (1984) (0)
Lithium in the prophylaxis of depressive illness in late life (1989) (0)
2. PSYCHIATRY: Recent Advances in Biological Psychiatry. (1964) (0)
Neurosurg . Psychiat . , 1971 , 34 , 30-31 Urine concentration in depressive illness (0)
Lithium dosage and prophylaxis. A double-blind controlled study (1984) (0)
S-63-5 The prevention of mortality in bipolar disorder (1996) (0)
Do Tricyclic Antidepressants Work? (1976) (0)
Technic and accuracy of the dexamethasone suppression test. (1983) (0)
Saliva-serum of tritium after the administration of tritiated water. (1960) (0)
WORKSHOP ON THECLINICAL PHARMACOLOGYAND EFFICACYOFMIANSERIN (1978) (0)
Letter: Treatment of unpolar depression. (1976) (0)
WHO COLLABORATIVE STUDY ON THE USE OF THE DE METHASO E SUPPRESSION TEST AS A BIOLOGICAL INDICATOR OF DEPRESSIVE ILLNESS (1984) (0)
The transfer of 35 S-methionine sulphone across the blood-cerebrospinal fluid barrier 1 (0)
Treatment of depression and pharmaceutical preparations for it. (1999) (0)
Cortisol inthecerebrospinal fluid ofpatients suffering fromaffective disorders (1971) (0)
The Biology of Manic Depressive Illness (The Ole Rafaelsen Memorial Lecture) (1988) (0)
USE OF MONOAMINE-OXIDASE INHIBITORS (1965) (0)
OBITUARY (1958) (0)
Subject Index Vol. 6, 1980 (1980) (0)
[A new antidepressive agent. Mianserin hydrochloride (Tolvin)]. (1978) (0)

This paper list is powered by the following services:

Alec James Coppen's Academic­Influence.com Rankings

Why Is Alec James Coppen Influential?

Alec James Coppen's Published Works

Published Works

Alec James Coppen's AcademicInfluence.com Rankings